Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
NRX Pharmaceuticals Inc (NASDAQ: NRXP) closed the day trading at $2.39 down -0.83% from the previous closing price of $2.41. In other words, the price has decreased by -$0.83 from its previous closing price. On the day, 0.6 million shares were traded. NRXP stock price reached its highest trading level at $2.45 during the session, while it also had its lowest trading level at $2.3301.
Ratios:
For a better understanding of NRXP, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.29 and its Current Ratio is at 0.29.
Upgrades & Downgrades
In the most recent recommendation for this company, H.C. Wainwright on September 08, 2025, initiated with a Buy rating and assigned the stock a target price of $40.
On April 02, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $18.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NRXP now has a Market Capitalization of 70756312 and an Enterprise Value of 70225328. For the stock, the TTM Price-to-Sale (P/S) ratio is 294.82. Its current Enterprise Value per Revenue stands at 290.187 whereas that against EBITDA is -4.62.
Stock Price History:
The Beta on a monthly basis for NRXP is 1.92, which has changed by -0.35904253 over the last 52 weeks, in comparison to a change of 0.16623151 over the same period for the S&P500. Over the past 52 weeks, NRXP has reached a high of $6.01, while it has fallen to a 52-week low of $1.58. The 50-Day Moving Average of the stock is -3.24%, while the 200-Day Moving Average is calculated to be -10.18%.
Shares Statistics:
Over the past 3-months, NRXP traded about 498.59K shares per day on average, while over the past 10 days, NRXP traded about 571800 shares per day. A total of 27.68M shares are outstanding, with a floating share count of 26.18M. Insiders hold about 11.55% of the company’s shares, while institutions hold 23.50% stake in the company. Shares short for NRXP as of 1765756800 were 1744957 with a Short Ratio of 3.50, compared to 1763078400 on 1358460. Therefore, it implies a Short% of Shares Outstanding of 1744957 and a Short% of Float of 6.2700000000000005.
Earnings Estimates
As of right now, 1.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.02, with high estimates of -$0.02 and low estimates of -$0.02.
Analysts are recommending an EPS of between -$1.42 and -$1.42 for the fiscal current year, implying an average EPS of -$1.42. EPS for the following year is $0.13, with 1.0 analysts recommending between $0.13 and $0.13.
Revenue Estimates
For the next quarter, 4 analysts are estimating revenue of $14.25M. There is a high estimate of $22.5M for the next quarter, whereas the lowest estimate is $6M. Based on 4 analysts’ estimates, the company’s revenue will be $111.84M in the next fiscal year. The high estimate is $241.4M and the low estimate is $40M.
